CI
MRNA icon

Conning Inc’s Moderna MRNA Stock Holding History

Conning Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,121
Closed -$252K – 360
2024
Q2 		$252K Buy
2,121
+43
+2% +$5.44K 0.01% 312
2024
Q1 		$221K Hold
2,078
– – 0.01% 334
2023
Q4 		$207K Buy
+2,078
New +$175K 0.01% 340
2023
Q2 		– Sell
-1,619
Closed -$249K – 371
2023
Q1 		$249K Sell
1,619
-28
-2% -$4.62K 0.01% 324
2022
Q4 		$296K Sell
1,647
-792
-32% -$129K 0.01% 308
2022
Q3 		$288K Sell
2,439
-174
-7% -$26.4K 0.01% 298
2022
Q2 		$373K Sell
2,613
-27
-1% -$3.86K 0.01% 279
2022
Q1 		$455K Sell
2,640
-440
-14% -$74.1K 0.01% 272
2021
Q4 		$782K Buy
3,080
+80
+3% +$23.4K 0.02% 205
2021
Q3 		$1.16M Buy
+3,000
New +$1.11M 0.03% 187

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Conning Inc's MRNA Position: Q3 2024 in Review

Conning Inc sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,121 shares — an estimated $252K sold.

Conning Inc first reported a position in MRNA in Q3 2021 and held it in 10 quarters. The position peaked at $1.16M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Conning Inc reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Conning Inc sold 2,121 Moderna shares in Q3 2024, an estimated $252K.
  • Conning Inc first reported a position in Moderna in Q3 2021 and held it in 10 quarters.
  • Conning Inc's Moderna position peaked at $1.16M in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Conning Inc's 13F filing for Q3 2024, filed 29 Oct 2024.